Glenmark Pharmaceuticals Limited

GLENMARK.NS·NSE·Healthcare
Compare
2,210.20−16.50 (−0.74%)today
At close: Oct 19, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,226.70
Open2,230.10
Day range2,200.002,269.90
52-week range1,792.602,537.60
Off day high−2.63%
Off 52-week high−12.90%
Volume285.70K
Avg. volume (3M)548.93K
Market cap623.77B
EPS (TTM)63.69
Forward P/E22.79
P/E ratio (TTM)34.70
Dividend yield0.11% (2.50)
Beta (5Y)0.25
Shares outstanding282.22M
Short interest—
Earnings dateJul 31, 2026 (est.)
Analyst target2,512.82
Profit margin10.14%

Against its peers

Compare in full ›
GLENMARK.NS ALVO GUD.TO AQST 1801.HK ABBV.NE
Market cap 623.77B 1.82B 1.13B 509.58M 152.41B 686.07B
P/E (TTM) 34.7 — 76.4 — 115.0 206.9
Forward P/E 22.8 22.2 44.1 -7.1 34.5 —
Price/book 5.9 -9.5 1.4 -9.0 6.2 -19.1
Dividend yield 0.11% — — — — 2.95%
1-year change +20.01% −40.96% +93.00% −45.60% +3.43% +24.96%
Today −0.74% +1.55% +1.33% +6.01% −1.85% 0.00%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

From articles in the 4Search news index.

In the news

4mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.